Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.
The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.
